Skip to main content

Table 1 Comparison of participants and non-participants

From: Recruitment and participant baseline characteristics in the dialysis outcomes in those aged 65 years or older study

  

Participated (N = 225)

Declined to participate (N = 107)

chi2 p value

  

n

%

n

%

Gender

 Male

144

64.0

49

45.8

 

 Female

81

36.0

58

54.2

0.002

Age group

 65–69

87

38.7

50

46.7

 

 70–74

64

28.4

36

33.6

 

 75–79

45

20.0

12

11.2

0.097

 80+

29

12.9

9

8.4

 

 median age

71

70

 

Ethnicity (as in ANZDATA)

 European

108

48.0

11

10.3

 

 Māori

45

20.0

24

22.4

 

 Pacific

53

23.6

52

48.6

0.000

 Other

19

8.4

19

17.8

 

 Missing

0

0.0

1

0.9

 

Ethnicity (Self reported multiple ethnicities were prioritised)

 Europeans

96

42.7

 

 Māori

50

22.2

 

 Pacific

52

23.1

 Other

27

12.0

 

Receiving dialysis

 Yes

169

75.1

68

63.6

 

 No

56

24.9

39

36.4

0.029

Living Arrangement

 Alone

33

14.7

 Living with others

192

85.3

 

Cigarette smoking

 Current smoker

14

6.2

 

 Ex smoker

118

52.4

 

 Never smoker

91

40.4

 Missing

2

0.9

 

Alcohol drinker

 Current drinker

96

42.7

 Non drinker

129

57.3

 

Highest educational qualification

 None

108

48.0

 

 Secondary (age 13–18)

44

19.6

 

 Post secondary

69

30.7

 Missing

4

1.8

 

Comorbiditiesa

 Cardiovascular disease

151

67.1

68

63.6

0.52

 Cerebrovascular disease

17

7.6

4

3.7

0.18

 Peripheral vascular disease

45

20.0

21

19.6

0.94

 Diabetes mellitus

120

53.3

80

74.8

< 0.01

 Respiratory disease

49

21.8

12

11.2

0.02

 Cancer (other than skin cancer)

38

16.9

8

7.5

0.02

 Musculoskeletal

68

30.2

32

29.9

0.95

 Other

140

62.2

81

75.7

0.02

Comorbidity count

 0 to 2

104

46.2

40

37.4

 

 3 to 6

121

53.8

67

62.6

0.13

Cause of ESKD

 Glomerulonephritis

38

16.9

15

14.0

 

 Hypertension

38

16.9

10

9.3

 

 Polycystic kidney

12

5.3

0

0.0

< 0.01

 Diabetes mellitus

92

40.9

68

63.6

 

 Other

45

20.0

14

13.1

 
  1. amultiple comorbidities possible